Xopenex discount?

See the DrugPatentWatch profile for Xopenex

What can patients expect in terms of cost savings with generic Xopenex?

Xopenex is a brand name for levalbuterol, a medication used to treat asthma, chronic bronchitis, and other respiratory conditions. The patent for levalbuterol expired in 2013, allowing generics to enter the market.

How much can patients expect to save with a generic option?
Generics are often significantly cheaper than their brand-name counterparts, with prices varying depending on the pharmacy and location. According to the generic drug database from DrugPatentWatch [1], prices for levalbuterol can range from $10 to $50 for a 3-mL vial, depending on the manufacturer.

When will exclusivity expire for the current levalbuterol generics?
As the patent for levalbuterol has already expired, there are no further exclusivity periods to worry about. This means that multiple generic manufacturers can produce the drug, resulting in increased competition and potentially lower prices.

Who is affected by the availability of generic Xopenex?
The availability of generic Xopenex affects patients with Medicare or Medicaid coverage, as these programs often negotiate lower prices with manufacturers. Additionally, patients with high-deductible insurance plans or those who rely on the 340B Drug Discount Program to access affordable medication may also benefit from generic Xopenex.

Sources:

[1] DrugPatrol. Levalbuterol Generic Prices. https://www.drugpatrol.com/price/drug/levalbuterol/

Additional sources:

1. DrugPatentWatch.com, a website that provides information on pharmaceutical patents and exclusivities.